Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Natural Killer T-Cells/metabolism"'
Autor:
Kent Riemondy, Anjana Rao, Brian P. O'Connor, S. Harsha Krovi, Laurent Gapin, Adam R. Lefferts, Jay R. Hesselberth, Leonard L. Dragone, Catherine Halluszczak, Philippa Marrack, Jingjing Zhang, Lisa K. Peterson, Kathryn D. Tuttle, Laura Harmacek, James P. Scott-Browne, Romain Bedel
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Nature Communications
Nature communications, vol. 9, no. 1, pp. 2650
Nature Communications
Nature communications, vol. 9, no. 1, pp. 2650
During development in the thymus, invariant natural killer T (iNKT) cells commit to one of three major functionally different subsets, iNKT1, iNKT2, and iNKT17. Here, we show that T cell antigen receptor (TCR) signal strength governs the development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f89e4c35d3becfa75c6b45c62a82a633
http://link.springer.com/article/10.1038/s41467-018-05026-6
http://link.springer.com/article/10.1038/s41467-018-05026-6
Publikováno v:
Molecular immunology. 101
Multiple myeloma (MM) is a progressive monoclonal B cell malignancy, for which survival and progression largely relies on the crosstalk of tumor cells with the bone marrow (BM) microenvironment, inducing immune escape, angiogenesis, bone destruction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a11624e8d80b6684960ec924afc4795d
https://pubmed.ncbi.nlm.nih.gov/30153633
https://pubmed.ncbi.nlm.nih.gov/30153633
Autor:
Emilie Bialecki, François Trottein, Luis J. Cruz, Josette Fontaine, Reem Ghinnagow, Elodie Macho-Fernandez, Benoît Frisch, Christelle Faveeuw
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, 193(2), 961-969
Journal of Immunology, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Journal of Immunology, 193(2), 961-969
Journal of Immunology, 2014, 193 (2), pp.961-969. ⟨10.4049/jimmunol.1303029⟩
Immunotherapy aiming at enhancing innate and acquired host immunity is a promising approach for cancer treatment. The invariant NKT (iNKT) cell ligand α-galactosylceramide (α-GalCer) holds great promise in cancer therapy, although several concerns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d564a81d30efc92538f3b7fbb6a0b5
https://www.hal.inserm.fr/inserm-02436034
https://www.hal.inserm.fr/inserm-02436034
Autor:
Matthias Hornung, Jens M. Werner, Stefan A. Farkas, Edward K. Geissler, Elisabeth Busl, Hans J. Schlitt
Publikováno v:
BMC Immunology
BMC Immunology, Vol 12, Iss 1, p 26 (2011)
BMC Immunology, Vol 12, Iss 1, p 26 (2011)
Background Natural killer T cells represent a linkage between innate and adaptive immunity. They are a heterogeneous population of specialized T lymphocytes composed of different subsets. DX5+NKT cells are characterized by expression of the NK cell m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc38bbc857ef45c010033fa44d99dd3b
https://pubmed.ncbi.nlm.nih.gov/21529347
https://pubmed.ncbi.nlm.nih.gov/21529347